Structure activity relationship study of benzo[d]thiazol-2(3H)one based σ receptor ligands

Bhat, Rohit; Fishback, James A.; Matsumoto, Rae R.; Poupaert, Jacques H.; McCurdy, Christopher R.

doi:10.1016/j.bmcl.2013.06.032

Cited by 6 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[77] These studies revealed the importance of distance between the benzothiazolone core and the pendant piperidine unit, with a shorter chain length to be preferred throughout the series. Alkyl substitutions and a long linker chain resulted in high affinity sigma ligands with low selectivity.…”

Section: Cyclic Amine Ligandsmentioning

confidence: 99%

Recent Advances in the Development of Sigma-1 Receptor Ligands

et al. 2015

View full text Add to dashboard Cite

The existence of two distinct sigma (s) receptor subtypes was established in the early 1990s. Sigma-1 and sigma-2 receptors (S1Rs and S2Rs, respectively) were shown to possess distinct molecular size, anatomical distribution, and ligand discrimination. S2R is overexpressed in numerous human cancers, and has therapeutic potential for the imaging and treatment of certain tumours. In contrast, S1R is more broadly involved in a wide variety of central nervous system (CNS) diseases including motor disorders, memory deficits, depression, schizophrenia, anxiety, pain, drug addiction, and many more. Since the human S1R was cloned in 1996, numerous high affinity ligands with excellent selectivity for S1R have been developed. This review focuses on recent developments in the generation of structurally diverse S1R-selective ligands and novel therapeutic candidates targeting S1Rs. include medicinal chemistry, heterocyclic chemistry, drug discovery, and structure-activity relationships of molecules with activity in the central nervous system. He serves on several journal editorial boards focussing on medicinal chemistry, pharmaceutical design and drug discovery.

show abstract

Section: Cyclic Amine Ligandsmentioning

confidence: 99%